One Jumped 13%, Another 6%: What's Powering These ASX Movers?
Source: Kapitales Research
Highlights:
A double-digit rally put one ASX stock firmly in the spotlight.
Investors continued backing a healthcare growth story with global potential.
A well-known energy company gained ground as buyers sought defensive exposure.
Several ASX-listed companies attracted strong investor interest on Thursday, with Treasury Wine Estates Limited, Telix Pharmaceuticals Limited and Ampol Limited emerging among the notable gainers. The trio benefited from a combination of company-specific optimism, sector strength and improving market sentiment.
Stocks in Focus:
Treasury Wine Estates Limited (ASX: TWE) rose 12.9% to $4.650
Telix Pharmaceuticals Limited (ASX: TLX) gained 6.5% to $12.955
Treasury Wine Estates delivered the strongest performance among the three stocks, with shares surging almost 13%. Investors appeared encouraged by improving sentiment towards premium consumer brands and the company’s long-term earnings prospects. The wine producer has continued to focus on strengthening its premium portfolio and expanding its presence across key international markets. Investors appeared encouraged by the company's efforts to strengthen its market position and drive sustainable growth despite a challenging operating environment.
Telix Continues to Attract Investor Support
Telix Pharmaceuticals recorded another solid gain as investors maintained confidence in the healthcare group's growth trajectory. The company remains well positioned within the radiopharmaceutical sector, supported by an expanding product portfolio and ongoing commercial progress. Market participants continue to view Telix as a company with significant long-term potential, particularly as demand for precision medicine and targeted cancer treatments increases globally.
Ampol Benefits from Defensive Appeal
Ampol also moved higher, supported by investor demand for businesses with resilient earnings profiles and attractive dividend characteristics. The company’s extensive fuel retail network and diversified operations have helped maintain confidence in its ability to generate stable cash flows. Improving sentiment towards energy-related stocks further contributed to the positive share price performance during the session.
Market Significance
The gains recorded by Treasury Wine Estates, Telix Pharmaceuticals and Ampol highlight the market’s ongoing preference for companies with strong fundamentals, earnings resilience and visible growth opportunities. As investors continue to navigate an uncertain economic environment, businesses demonstrating operational strength and long-term potential remain well placed to attract capital.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
One Jumped 13%, Another 6%: What's Powering These ASX Movers?
Highlights:
Several ASX-listed companies attracted strong investor interest on Thursday, with Treasury Wine Estates Limited, Telix Pharmaceuticals Limited and Ampol Limited emerging among the notable gainers. The trio benefited from a combination of company-specific optimism, sector strength and improving market sentiment.
Stocks in Focus:
Treasury Wine Estates Leads the Charge
Treasury Wine Estates delivered the strongest performance among the three stocks, with shares surging almost 13%. Investors appeared encouraged by improving sentiment towards premium consumer brands and the company’s long-term earnings prospects. The wine producer has continued to focus on strengthening its premium portfolio and expanding its presence across key international markets. Investors appeared encouraged by the company's efforts to strengthen its market position and drive sustainable growth despite a challenging operating environment.
Telix Continues to Attract Investor Support
Telix Pharmaceuticals recorded another solid gain as investors maintained confidence in the healthcare group's growth trajectory. The company remains well positioned within the radiopharmaceutical sector, supported by an expanding product portfolio and ongoing commercial progress. Market participants continue to view Telix as a company with significant long-term potential, particularly as demand for precision medicine and targeted cancer treatments increases globally.
Ampol Benefits from Defensive Appeal
Ampol also moved higher, supported by investor demand for businesses with resilient earnings profiles and attractive dividend characteristics. The company’s extensive fuel retail network and diversified operations have helped maintain confidence in its ability to generate stable cash flows. Improving sentiment towards energy-related stocks further contributed to the positive share price performance during the session.
Market Significance
The gains recorded by Treasury Wine Estates, Telix Pharmaceuticals and Ampol highlight the market’s ongoing preference for companies with strong fundamentals, earnings resilience and visible growth opportunities. As investors continue to navigate an uncertain economic environment, businesses demonstrating operational strength and long-term potential remain well placed to attract capital.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au